Determining drug inhibition profiles and opportunities for synergistic combination therapies in head and neck cancer cell lines

被引:0
|
作者
Zoergiebel, Johanna
Kundu, Abir
Braegelmann, Johannes
Shen, Wanda
El Dinah, Mohamed
Salgia, Ravi
Seiwert, Tanguy
机构
关键词
D O I
10.1158/1535-7163.TARG-09-A165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A165
引用
收藏
页数:3
相关论文
共 50 条
  • [1] MicroRNA expression profiles in head and neck cancer cell lines
    Tran, Nham
    McLean, Tessa
    Zhang, Xiaoying
    Zhao, Chuan Jia
    Thomson, John Michael
    O'Brien, Christopher
    Rose, Barbara
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (01) : 12 - 17
  • [2] Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(-) Head and Neck Cancer Cell Lines
    Ludwig, Sonja
    Sharma, Priyanka
    Theodoraki, Marie-Nicole
    Pietrowska, Monika
    Yerneni, Saigopalakrishna S.
    Lang, Stephan
    Ferrone, Soldano
    Whiteside, Theresa L.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Pathway profiling of head and neck cancer cell lines
    Zuo, Zhixiang
    Braegelmann, Johannes
    Keck, Michaela
    Shen, Wanda
    El Dinali, Mohamed
    Vokes, Everett E.
    Seiwert, Tanguy Y.
    CANCER RESEARCH, 2012, 72
  • [4] In vitro chemosensitivity of head and neck cancer cell lines
    PJ Schuler
    S Trellakis
    J Greve
    M Bas
    C Bergmann
    E Bölke
    G Lehnerdt
    S Mattheis
    AE Albers
    S Brandau
    S Lang
    TL Whiteside
    H Bier
    TK Hoffmann
    European Journal of Medical Research, 15
  • [5] Oxaliplatin activity in head and neck cancer cell lines
    Magali Espinosa
    Moises Martinez
    José Luis Aguilar
    Aída Mota
    Jaime G. De la Garza
    Vilma Maldonado
    Jorge Meléndez-Zajgla
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 301 - 305
  • [6] IN VITRO CHEMOSENSITIVITY OF HEAD AND NECK CANCER CELL LINES
    Schuler, P. J.
    Trellakis, S.
    Greve, J.
    Bas, M.
    Bergmann, C.
    Boelke, E.
    Lehnerdt, G.
    Mattheis, S.
    Albers, A. E.
    Brandau, S.
    Lang, S.
    Whiteside, T. L.
    Bier, H.
    Hoffmann, T. K.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (08) : 337 - 344
  • [7] Oxaliplatin activity in head and neck cancer cell lines
    Espinosa, M
    Martinez, M
    Aguilar, JL
    Mota, A
    De la Garza, JG
    Maldonado, V
    Meléndez-Zajgla, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (03) : 301 - 305
  • [8] Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
    Nasredine Aissat
    Christophe Le Tourneau
    Aïda Ghoul
    Maria Serova
    Ivan Bieche
    François Lokiec
    Eric Raymond
    Sandrine Faivre
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 305 - 313
  • [9] Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
    Aissat, Nasredine
    Le Tourneau, Christophe
    Ghoul, Aida
    Serova, Maria
    Bieche, Ivan
    Lokiec, Francois
    Raymond, Eric
    Faivre, Sandrine
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 305 - 313
  • [10] Combination of betulinic acid with cisplatin - different cytotoxic effects in two head and neck cancer cell lines
    Eder-Czembirek, C
    Czembirek, C
    Erovic, BM
    Selzer, E
    Turhani, D
    Vormittag, L
    Thurnher, D
    ONCOLOGY REPORTS, 2005, 14 (03) : 667 - 671